ETF Building Blocks ChannelALPS ‘SBIO’ ETF: Trial Progress Meets Investing SuccessBy Tom LydonJanuary 25, 2021
ETF Building Blocks ChannelDon’t Miss Out on Rampant Biotech Mergers with the SBIO ETFBy Tom LydonJanuary 13, 2021
Innovative ETFs ChannelConsider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021By Max ChenDecember 31, 2020
ETF Building Blocks ChannelHow Increased FDA Activity Can Benefit ETFs in Your PortfolioBy Tom LydonNovember 19, 2020
ETF Building Blocks ChannelMore than Just COVID: Hot ETFs for Medical BreakthroughsBy Tom LydonNovember 5, 2020
ETF Building Blocks ChannelPost-Election Considerations for a Nifty Biotech ETFBy Tom LydonOctober 7, 2020
ETF Building Blocks ChannelA Healthcare ETF Could Benefit From Index ReshufflingBy Tom LydonJune 23, 2020
ETF Building Blocks ChannelBiotech ETF Doesn’t Need Coronavirus Vaccines to SoarBy Tom LydonJune 2, 2020
Disruptive Technology ChannelBiotech ETFs Are Not Riding the Wave from Coronavirus PanicBy Max ChenJanuary 24, 2020
Innovative ETFs ChannelETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC) By Aaron NeuwirthDecember 12, 2019
